StairMed sits in China’s invasive BCI segment, with ultra-flexible electrodes, wireless implants, and robotic implantation forming the core platform logic. Its positioning is differentiated by a vertically integrated approach that links neural interfaces, implantation tools, and clinical translation workflows.